Investment Research & Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-109
Closed -$13.2K 319
2026
Q1
$13.2K Hold
109
﹤0.01% 194
2025
Q4
$13.1K Hold
109
﹤0.01% 180
2025
Q3
$13K Hold
109
﹤0.01% 166
2025
Q2
$9.5K Sell
109
-93
-46% -$7.89K ﹤0.01% 173
2025
Q1
$18.2K Buy
202
+93
+85% +$8.32K 0.01% 148
2024
Q4
$8.71K Hold
109
﹤0.01% 162
2024
Q3
$9.81K Hold
109
﹤0.01% 157
2024
Q2
$8.58K Hold
109
﹤0.01% 155
2024
Q1
$9.5K Hold
109
﹤0.01% 154
2023
Q4
$8.98K Hold
109
﹤0.01% 151
2023
Q3
$8.54K Hold
109
﹤0.01% 152
2023
Q2
$9.6K Hold
109
0.01% 160
2023
Q1
$8.79K Hold
109
0.01% 142
2022
Q4
$8.47K Hold
109
0.01% 141
2022
Q3
$9K Hold
109
0.01% 132
2022
Q2
$10K Hold
109
0.01% 132
2022
Q1
$12K Hold
109
0.01% 147
2021
Q4
$11K Hold
109
0.01% 156
2021
Q3
$14K Buy
109
+34
+45% +$4.4K 0.01% 127
2021
Q2
$9K Buy
+75
New +$9.42K 0.01% 138

Other funds holding MDT

Investment Research & Advisory Group's MDT Position: Q2 2026 in Review

Investment Research & Advisory Group sold out of Medtronic (MDT) in Q2 2026, closing a stake of 109 shares — an estimated $13.2K sold.

Investment Research & Advisory Group first reported a position in MDT in Q2 2021 and held it in 20 quarters. The position peaked at $18.2K in Q1 2025. 858 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Investment Research & Advisory Group reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Investment Research & Advisory Group sold 109 Medtronic shares in Q2 2026, an estimated $13.2K.
  • Investment Research & Advisory Group first reported a position in Medtronic in Q2 2021 and held it in 20 quarters.
  • Investment Research & Advisory Group's Medtronic position peaked at $18.2K in Q1 2025.
  • 858 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Investment Research & Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.